CompuMed, Inc. (CMPD)
6.39
-0.04
(-0.62%)
USD |
OTCM |
Oct 02, 16:00
CompuMed Gross Profit Margin (Quarterly) : 49.53% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.53% |
| March 31, 2026 | 48.07% |
| December 31, 2025 | 47.47% |
| September 30, 2025 | 47.47% |
| June 30, 2025 | 47.93% |
| March 31, 2025 | 45.40% |
| December 31, 2024 | 46.83% |
| September 30, 2024 | 47.32% |
| June 30, 2024 | 48.65% |
| March 31, 2024 | 47.96% |
| December 31, 2023 | 50.78% |
| September 30, 2023 | 47.56% |
| June 30, 2023 | 50.66% |
| March 31, 2023 | 49.09% |
| December 31, 2022 | 50.37% |
| September 30, 2022 | 50.13% |
| June 30, 2022 | 51.55% |
| March 31, 2022 | 53.27% |
| December 31, 2021 | 52.69% |
| September 30, 2021 | 52.80% |
| June 30, 2021 | 53.09% |
| March 31, 2021 | 54.64% |
| December 31, 2020 | 51.07% |
| September 30, 2020 | 54.53% |
| June 30, 2020 | 55.91% |
| Date | Value |
|---|---|
| March 31, 2020 | 50.55% |
| December 31, 2019 | 50.42% |
| September 30, 2019 | 55.82% |
| June 30, 2019 | 51.57% |
| March 31, 2019 | 51.29% |
| December 31, 2018 | 48.50% |
| September 30, 2018 | 50.62% |
| June 30, 2018 | 46.54% |
| March 31, 2018 | 49.11% |
| December 31, 2017 | 45.02% |
| September 30, 2017 | 49.18% |
| June 30, 2017 | 53.18% |
| March 31, 2017 | 47.86% |
| December 31, 2016 | 43.95% |
| September 30, 2016 | 44.75% |
| June 30, 2016 | 45.67% |
| March 31, 2016 | 43.65% |
| December 31, 2015 | 37.81% |
| September 30, 2015 | 42.81% |
| June 30, 2015 | 42.71% |
| March 31, 2015 | 45.68% |
| December 31, 2014 | 45.39% |
| September 30, 2014 | 43.28% |
| June 30, 2014 | 47.06% |
| March 31, 2014 | 45.65% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Renalytix Plc | -- |
| RadNet, Inc. | 7.89% |
| DarioHealth Corp. | 61.66% |
| Net Medical Xpress Solutions, Inc. | -- |
| Evolent Health, Inc. | 9.08% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.94% |
| Return on Assets | -5.74% |
| Return on Invested Capital | -7.38% |
| Profit Margin (Quarterly) | 1.14% |
| Operating Margin (Quarterly) | 0.82% |
| Return on Net Operating Assets | -8.87% |